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INTRODUCTION 
Midline anomalies encompasses a heterogeneous group of conditions caused by an abnormal 
process of ventral induction after the end of primary neurulation1 (Table 1). Classification systems 
for brain midline anomalies are varied and continuously improving as the underlying embryology 
and genetics are still partially uncovered. A relatively simple and robust classification system is 
based on the location of abnormalities, assuming that the large majorities of such anomalies 
involved different part of fetal brain. These anomalies are among the most common central nervous 
system (CNS) malformations diagnosed on prenatal ultrasound. Advances in prenatal imaging 
techniques have led to an increase in the detection rate of such anomalies since the first trimester of 
pregnancy although a significant proportion of them remain undiagnosed until birth. Although the 
most severe anomalies involving the midline, such as holoprosencephaly, can be detected on a basic 
examination of the fetal brain, others require a detailed assessment of cerebral structures through 
axial, sagittal and coronal views of the brain, thus explaining the relatively low detection rate 
reported in the published literature. Ultrasound is the primary technique in detecting such anomalies 
while fetal magnetic resonance imaging (MRI) is commonly performed to confirm the diagnosis 
and detect additional anomalies, especially those involving the cortical surface of the brain, which 
may potentially impact post-natal outcome. Neurodevelopmental outcome of cerebral anomalies 
involving the midline is directly related to the type of anomaly, cause and presence of associated 
anomalies. However, even in case of isolated anomalies prenatal counselling is challenging. 
The aim of this review is to provide an up to date on the diagnosis, counselling and management of 
the most common supra-tentorial anomalies involving the midline and diagnosed on prenatal 
ultrasound.  
 
EMBRIOLOGY 
Development of midline structures begins at the end of prosencephalic maturation after primary 
neurulation, a series of inductive events that result in the formation of the brain and spinal cord. 
Prosencephalic development is characterized by three sequential events: prosencephalic formation 
(at the rostral end of the neural tube), cleavage and midline development1-2. In particular, during 
prosencephalic cleavage, three main splitting events occurs: horizontal, to form the paired optic 
vescicles, olfactory bulbs and tracts, transverse, in which telencephalon separates from diecephalon 
and sagittal, to form the cerebral hemispheres, lateral ventricles and basal ganglia. Prosencephalic 
development is characterized by appearance of three plates of tissue: the commissural, the 
chiasmatic and the hypothalamic plates. These structures are fundamental in the development of the 
corpus callosum (CC), cavum septum pellucidi (CSP), optic nerve chiasm and hypothalamic 
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structures1. Formation of the main cerebral commissures, including CC, anterior and the 
hippocampal commissures, involves multiple steps3. The CC development is not completed in utero 
but continues during neonatal period and infancy4. 
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ASSESSMENT OF SUPRATENTORIAL MIDLINE STRUCTURES IN THE FETUS 
Ultrasound assessment of fetal CNS is feasible since the first trimester of pregnancy although a 
precise assessment of intra-cranial structures is possible only from the second trimester onwards, at 
the time of the anomaly scan. Transabdominal sonography is usually the technique of choice to 
perform a basic examination of fetal CNS, while transvaginal ultrasound is commonly used to 
acquire coronal and sagittal views of the brain which can help in the differential diagnosis, but 
which are not easy to obtain with a trans-abdominal approach. 
According to the International Society of Ultrasound in Obstetrics and Gynecology, a basic 
examination of supra-tentorial brain structures should include the visualization of two axial planes, 
trans-ventricular and trans-thalamic5. The structures that should be noted in the routine examination 
include the interhemispheric fissure, frontal horns of the lateral ventricles, CPS, thalami and 
posterior horn of the ventricles. Interhemispheric fissure appears as an echogenic line starting from 
the frontal part of the calvarium and it commonly visible since 8-9 weeks of gestation. Frontal horns 
of the lateral ventricles appear as two comma-shaped fluid filled structures, a well defined lateral 
wall, and medially are separated by the CSP. CSP is a fluid filled cavity between two thin 
membranes which undergoes obliteration in late pregnancy or in the early neonatal period. CSP can 
be detected since 16 weeks of gestation and should be always visible between 18 and 37 weeks 
(Figure 1). Visualization of the CSP is fundamental to assess the integrity of CC, which cannot be 
identifies on axial views of the brain but require acquisition of sagittal and coronal planes. Recently, 
ultrasound assessment of the anterior complex, defined as the group of all the anatomical structures 
visible in a routine trans-ventricular plane of the fetal brain, has been proposed to improve the 
detection rate of supra-tentorial midline anomalies6.  
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ANOMALIES OF THE CORPUS CALLOSUM: COMPLETE AND PARTIAL AGENESIS  
1. Diagnostic features and prevalence  
The corpus callosum (CC) is the largest white matter commissure of the human brain; it contains 
about 200 million axons connecting the left and the right cerebral hemispheres with a fundamental 
role in the integration of sensory, motor, visuomotor, and cognitive processes7-8.  
CC has four segments: the rostrum, genu, body and splenium; the narrowing between the body and 
splenium is called the isthmus. The corpus callosum develops between 8 and 20 weeks’ gestation 
with a cranio-caudally progression with the exception of the most anterior part called the rostrum 
that develops later9, although other studies suggest that CC development progresses 
bidirectionally10-13. 
There is wide variation in the terminology used to describe CC abnormalities, and such differences 
should be considered when assessing previous reports of outcomes in these conditions.  
The most common anomalies involving the CC are: 
• Agenesis (ACC), either complete (cACC) or partial (pACC) 
• Hypoplasia, characterized by the presence of a fully formed but thinner CC  
• Hyperplasia, characterized by the presence of a fully formed but tick CC 
• Dysplasia, defined as a CC with a hump shape  
 
Hypo-, hyper- and dysplasia of the CC are rarely diagnosed before birth, and most of the available 
series focus upon cACC or pACC. 
 
ACC is a rare clinical condition in which the main commissural pathway connecting the two 
homologous cortical hemispheres is partially (pACC) o completely (cACC) absent14.  
ACC is one of the most common congenital brain anomalies with an estimated incidence ranging 
from 1.8 per 10000 in the general population and 230-600 per 10000 in children with 
neurodevelopmental disabilities15-17. However, the actual incidence of ACC is difficult to estimate 
because of selection bias in reported series. The best available data probably come from the 
California Birth Monitoring Defect Program and suggest a prevalence of about 1.4 and 0.4 per 
10,000 live births for ACC and hypoplasia of corpus callosum respectively16. This figure may 
however be an underestimate of the real incidence as it is likely that in this study a large proportion 
of asymptomatic individuals escaped detection.  
ACC is associated with a large spectrum of CNS and extra-CNS anomalies in about 45% of cases, 
including neuronal migration disorders, interhemispheric cysts, posterior fossa malformations, 
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hypertelorism, cleft/lip palate, musculoskeletal, genitourinary, gastrointestinal disorders and 
congenital heart14,18.  
 
2. Etiology and pathophysiology  
ACC can be determined by a large variety of conditions, such as genetic, infectious, vascular or 
toxic.  
Chromosomal anomalies are commonly associated ACC, either complete or partial14,19. The most 
common chromosomal anomalies associated with ACC include trisomy 18, trisomy 13, and mosaic 
8.The risk of abnormal karyotype is higher in fetuses presenting with ACC associated with other 
CNS and extra-CNS anomalies and has been reported to be around 18%14.  
In isolated cases, abnormal karyotype occurs in 4.8% (95% CI 2.2–8.4) of cACC and in 7.5% (95% 
CI 2.0–15.9) of pACC respectively, thus highlighting the need for prenatal assessment of fetal 
karyotype also in these cases. 
   
Chromosomal microarray analysis (CMA) is a DNA-based method of genetic analysis, which can 
identify clinically significant chromosome abnormalities (gain and losses of DNA) that are below 
the resolution of conventional chromosome analysis, known as copy number variations (CNV)20-21. 
Fetuses with central nervous system (CNS) anomalies and normal karyotype have been shown to 
have a significantly higher risk of genetic anomalies at CMA analysis; furthermore, a higher 
incidence of CMA anomalies has been reported in children presenting with neuropsychological 
disabilities. In fetuses with isolated ACC, the rate of significant CNVs in fetuses with isolated ACC 
(either cACC or pACC) and normal karyotype has been reported to be 5.7% (95% CI, 1.3–13.1), 
thus highlighting the need for CMA even in case of isolated ACC on ultrasound. A recent joint 
committee opinion of the American College of Obstetricians and Gynecologists (ACOG) and the 
Society of Maternal-Fetal Medicine (SMFM) recommended that CMA analysis should be 
performed in fetuses undergoing invasive procedures for major structural anomalies detected on 
ultrasound20. 
 
Genetic factors are among the most common causes of ACC with more than 200 syndromes 
reported to be associated with this anomaly, involving either autosomal dominant, recessive and X-
linked mode of inheritance. The most common genetic syndromes associated with ACC are Aicardi 
(ACC, chorioretinal abnormalities, infantile seizures and mental retardation), Anderman (ACC, 
progressive motor-sensory neuropathy and mental retardation) and Acrocallosal (ACC, polydactyly, 
craniofacial anomalies, mental retardation) syndromes22-24.  
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Tubulinopathies, Smith-Lempli-Optiz syndrome, L1 syndrome can also be associated with ACC25. 
ACC has been also associated with mutation of FOXG-1 gene on chromosome 1 which leads to a 
peculiar phenotype characterized by callosal agenesis and delayed myelinization26-27. Children with 
this rare autosomal dominant disorder (also known as “atypical Rett syndrome”) show 
neurodevelopmental delay and Rett-like features (hypotonia, motor disorders, gastroesophageal 
reflux disease and microcephaly)28. ACC is also among the most frequent CNS malformation in 
children with Papilllon-Leage-Psaume syndrome, an oral-facial-digital syndrome caused by OFD1 
mutations29. 
Advances in genetic diagnostic techniques, such as Next-Generation Sequencing (NGS) like 
Whole-Exome (WES) and Whole-Genome Sequencing (WGS)20,30, may help in determining the 
underlying cause of ACC especially in those cases not presenting with the classical clinical features 
of a syndromic condition 31 and in fetus with normal karyotype and CMA. WES allows examination 
of nucleotide sequence of expressed genes in the genome. Compound heterozygous variants in the 
CDK5RAP2 gene (also known as MCPH3, a causative gene for autosomal recessive primary 
microcephaly), ZBTB20, C12ofr57 and other gene mutations30,32 have been described in patients 
with ACC33-36. These techniques, because ACC genetic heterogeneity, may play an important role in 
identifying cases affected by ACC at higher risk of intellectual disability. Despite this, identification 
of the underlying cause of ACC is achieved in less than 50% of the cases.  
Finally, ACC had been reported to occur in in association with congenital infections, such as 
Cytomegalovirus37-39, Toxoplasmosis40, Rubella38 and Influenza virus41 but they are commonly 
associated with other CNS and extra CNS anomalies, while the incidence of infection in isolated 
ACC is negligible. 
 
3. Prenatal diagnosis: ultrasound and fetal MRI  
On ultrasound, the CC can be identified in a median sagittal view of the fetal brain as a hypoechoic 
structure located between the cavum septi pellucidi (CSP) and the cingulate gyrus, demarcated by 
two echogenic lines42 (Figure 1). The peri-callosal artery, which develops in close association with 
the CC, can also act as a useful marker on 2D ultrasound imaging.   
Prenatal diagnosis of ACC on ultrasound is challenging and it is based upon the complete (cACC) 
or partial (pACC) non-visualization of the CC on midsagittal view of the fetal head14,43-44. Despite 
its importance, a direct visualization of the CC is not required on the standard examination of the 
fetal CNS performed at the time of the routine scan14, thus explaining the relatively low detection 
rate for ACC, in particular for pACC, reported in the recently published literature.  
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Trans-vaginal ultrasound is commonly the technique of choice when assessing a fetus with 
suspected ACC in vertex position, as it allows acquisition of sagittal and coronal planes of the brain 
which are fundamental to diagnose the anomaly (Table 2). Abnormal course of the pericallosal 
artery on midsagittal views fetal brain may also help in detecting ACC (Figure 2). In cACC, the 
semicircular loop of the pericallosal artery is lost and the branches of the anterior cerebral artery 
ascend linearly, while in pACC the pericallosal artery follows the anterior part of the corpus 
callosum but then loses its normal course where the corpus callosum disappears posteriorly and 
takes an upward posterior oblique direction 9,42,45 (Figure 2). A radial disposition of the sulci on the 
internal aspects of the hemispheres could be also be present on mid-sagittal views of the brain. 
ACC can be also suspected on axial views of the brain although most of the reported signs are not 
specific and are present almost exclusively in case of complete rather than partial agenesis. Absent 
visualization of the CSP from 18 weeks of gestation is the most common indirect sign which can 
raise the suspicion of ACC; it is observed only in case of cACC but is not specific for this condition 
as it is observed in other CNS anomalies such as holoprosencephaly, hydrocephalus, septo-optic 
dysplasia, schizencephaly, porencephaly and hydranencephaly46. When assessing the fetal brain on 
axial views it is important not to misinterpret the columns of the fornix, which lie at a more basal 
level, with CSP. Because the embryologic development of the fornix is not directly associated with 
that of the CC, its identification does not rule out ACC47. Such misinterpretation may be responsible 
of the higher rate of false negative diagnoses for ACC reported in the published literature. 
ACC causes a peculiar rearrangement of the midline supra-tentorial cerebral structures which can 
be detected on ultrasound. Lack of the CC induce a widening of the interemispheric fissure and the 
elevation of the third ventricle. Frontal horns of the lateral ventricles are usually displaced from the 
midline by a paired aberrant bundle of fibers (Bundle of Probst) that fail to cross the hemispheres 
and run parallel to the midline assuming the shape of a bull’s horn. The absence of the posterior part 
of the CC in complete agenesis induces a dilatation of the atria and occipital horns of the lateral 
ventricles known as colpocephaly, which can on the standard axial view at the trans-ventricular 
level (Figure 2).  
These signs are observed in case of cACC, while in partial agenesis, assessment of fetal brain on 
axial view can be unremarkable.  
3D ultrasound has recently shown to provide several advantages in the evaluation of the anatomy of 
intracranial structures such us the CC allowing a multiplanar assessment of the fetal brain starting 
from an axial view of the fetal head48-55.  
The presence of associated anomalies is one of the major determinants of the prognosis of fetuses 
affected by ACC. These may include abnormalities of cortical development, which can only be 
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assessed with advancing gestation. Serial follow-up scan during pregnancy are therefore warranted 
to search for cerebral and extra-cerebral abnormalities that may not be evident during the second-
trimester examination. However, there is no agreement in the literature regarding the timing and 
frequency of such follow-up scan in fetuses with ACC.  
A list of the ultrasound signs of ACC in the different imaging plane is shown in Table 2. 
 
When assessing fetuses with suspected callosal agenesis, it is important to state that ultrasound 
signs suggestive of ACC can change with gestation. 
In a retrospective series of 54 cases affected by complete and partial ACC, colpocephaly was 
present in 20.6% of fetuses scanned before weeks and in 68.6% of those after 24 weeks of gestation, 
while the corresponding figures for an atrial width >10 mm were 73.5% and 25.7% of cases 
respectively.  
CSP was present and visible in 63% of cases affected by pACC, while in 33.3% there was neither 
ventriculomegaly nor absence of CSP43.  
Fetal MRI is commonly performed in fetuses with suspected CNS anomalies and has been reported 
to add additional information compared to ultrasound which may significantly impact prognosis. 
Although the actual contribution of MRI compared to ultrasound in fetal CNS anomalies is difficult 
to quantify due to the large heterogeneity among the previously published studies, MRI is routinely 
used in clinical practice to confirm diagnosis and to look for associated anomalies in case of ACC. 
In a recent systematic review including only fetuses with isolated ACC, associated anomalies not 
detected on ultrasound were diagnosed on fetal MRI in 7.83% (95% CI, 1.2–19.6) and in 11.86% 
(95% CI, 3.2–24.9) of cACC and pACC. The large majority of such additional anomalies included 
neuronal migration disorders, which can be detected preferentially from the third trimester of 
pregnancy. In this scenario, it might be reasonable to arrange a fetal MRI in the third trimester of 
pregnancy to confirm that ACC is truly isolated, even in case MRI was performed earlier in 
gestation to confirm the diagnosis. 
More recently, a secondary analysis of the Meridian Study, a multicenter prospective cohort study 
involving over 800 pregnancies with a fetal brain abnormality undergoing ultrasound and MRI 
within 14 days, the diagnostic accuracy for detecting ACC was 40.0% for ultrasound and 92.7% for 
MRI. More importantly, prognostic information given to the women changed in 45.6% cases after 
MRI and its overall effect on clinical management was 'significant', 'major' or 'decisive' in 44.3%56. 
Although affected by the small sample size and lack of accurate description on how ultrasound 
assessment of the brain was performed, this data suggests a potential contribution of fetal MRI in 
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the diagnostic algorithm of fetuses affected by ACC, but it requires confirmation in larger and 
appropriately designed series. 
As reported from Paladini et al, the MERIDIAN trial does not describe the ultrasound approach 
whose diagnostic accuracy was compared to fetal MRI. It is underlined that MRI should represent a 
second-line resource to be employed in selected cases, and only after expert neurosonography57. 
However, even in cases of a prenatal diagnosis of isolated anomaly, the risk of ACC being not truly 
isolated is relatively high, with additional anomalies detected only at postnatal imaging and/or 
clinical examination reported to occur in 5.5% (95% CI 2.4–9.7) and 15.0% (95% CI 6.7-24.6) 
respectively, thus highlighting the need for a thorough post-natal assessment of these children. 
 
4. Neurodevelopmental outcome  
Assessing neurodevelopmental outcome in children affected by ACC is challenging. The main 
determinant of adverse outcome in children with ACC is the presence of associated CNS anomalies 
which can occur in about 45% of cases. However, even in case of a prenatal diagnosis of isolated 
ACC, the risk of additional anomalies detected only after birth is about 5% in cACC and 15% in 
pACC. 
The wide heterogeneity in inclusion criteria, antenatal imaging protocol adopted, 
neurodevelopmental tool used and time of follow up among the include studies does not allow to 
extrapolate an objective evidence on the actual burden of neurodevelopmental disabilities affecting 
fetuses with isolated ACC. Post-natal studies reports a high rate of abnormal neuropsychological 
outcome in children with ACC, such as intellectual abilities, difficulties in pragmatic language skills 
and impaired mathematics, expressive and receptive language, visual and spatial reasoning, and 
attentional skills. However, they are biased by the inclusion of mainly symptomatic cases, thus 
potentially overestimating the figures for intellectual disabilities reported. The term 
neurodevelopmental outcome is also misleading and inappropriate when dealing with brain 
anomalies, because it includes a wide spectrum of signs that are not always easily measured and 
that represent a continuous interaction between pathological, environmental, and adaptive factors. 
Time at assessment represent another potential confounder, early neuropsychological examination 
may not accurately predict neurodevelopmental outcomes during later life58, while late assessment 
may be biased by the influence of socio- economic, parenting, environmental, and educational 
factors, which may significantly affect developmental measures, especially when looking for subtle 
differences59. Finally, assessment of a control population may represent another considerable source 
of bias when assessing the diagnostic performance of children affected by brain anomalies. The risk 
for a given abnormal neurodevelopmental measure is commonly computed upon a control 
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population which should theoretically include “health” individuals, free from the anomaly and 
implies the knowledge of how this measure is abnormal in the cohort not affected by the anomaly. 
However, some series reported rates of abnormal neurodevelopmental outcome as high as 10%60, 
thus questioning whether different populations should be compared to estimate the risk of a given 
neuropsychological measure. 
 
A recent systematic review reported that 76.0% (95% CI 64.3–86.1) of children with a prenatal 
diagnosis of isolated cACC confirmed at birth had a normal neurodevelopmental outcome, 16.0% 
(95% CI 7.6–26.8) showed borderline to moderate impairment while 8.2% (95% CI 2.5–16.8) 
severe disabilities (Table 3). When looking at the different neurodevelopmental abilities, gross and 
fine motor skills were abnormal in 4.4% (95% CI 0.6-11.3) and 11.0% (95% CI 4.1-20.6) of cases, 
while cognitive anomalies in 15.2% (95% CI 6.9–25.9). Epilepsy occurred in 6.8% (95% CI 1.7–
14.9) of isolated cACC, while the corresponding figures for abnormal sensory, visual and 
coordination skills were 0% (95% CI 0-9.2), 15.8% (95% CI 4.3-32.9) and 9.5% (95% CI 3.2-18.7). 
Finally, abnormal language was detected in 8.0% (95% CI 2.1-17.3) of cases.  
In children with a prenatal diagnosis of isolated pACC confirmed at birth, a normal 
neurodevelopmental outcome was observed in 71.4% (95% CI 53.1–86.7) of cases, a mild to 
moderate impairment in 14.9% (95% CI 4.2–30.7) while severe disabilities in 12.5% (95% CI 2.9–
27.5). When looking at the individual component neurodevelopmental outcome, gross and fine 
motor skills were abnormal in 0% (95% CI 0-23.0) and 11.7% (95% CI 0.9-32.1), while cognitive 
skills in 17.3% (95% CI 3.0-39.7). Epilepsy occurred in 16.1% (95% CI 2.0-53.2) of cases with 
isolated pACC while there was no case of impaired sensory or visual skills although the number of 
cases included was very small. Finally, coordination and language were abnormal in 11.7% (95% CI 
0.9-32.2) and 17.3% (95% CI 3.0-39.7) of cases. 
 
However, these figures should be interpreted with caution; differences in type of assessment, length 
of follow-up and neurodevelopmental test used may have represented a considerable source of bias 
in estimating such figures. Furthermore, although cases included in that systematic review were 
considered to be isolated on the basis of standard karyotype and normal pre and post-natal imaging, 
it may be entirely possible that children carrying chromosomal anomalies identifiable only at CMA 
analysis or those with genetic syndrome not showing clear phenotypic anomalies were included in 
this cohort, thus potentially biasing the figures for abnormal neurodevelopmental measures 
reported. 
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These results are in contrast those reported in individuals undergoing commissurotomy which show 
a disconnection syndrome61, with complete lack of interhemispheric integration of sensory and 
motor information. Children with ACC usually show a normal ability to make comparison in 
particular of simple and familiar information. One theory to explain this preserved capacity is that 
this information could be transferred via others connecting pathways, such as the anterior 
commissure3, although this capacity may be limited by task complexity. Regarding language 
abilities, children with ACC have intact general naming62-63, receptive language63-64 and lexical 
reading skills65, while they could be impaired in the comprehension of syntax and linguistic 
pragmatics (such as idioms, proverbs, and narrative humor)66-67. They could also show difficulty in 
expressive language, in particular in the verbal expression of emotional experiences. Parents of 
children affected by ACC describe poor personal insight, social judgement and planning deficit, 
with poor communication of emotions that interfere with the daily lives of these children68-70, 
leading to an overlap with the diagnostic criteria for autism. ACC has also 
been linked with schizophrenia71-73, and individuals with this condition have been reported to have 
major morphological anomalies or microstructural changes in the CC on MRI74. 
 
5. Pre- and post-natal management 
Fetuses suspected to be affected by ACC on ultrasound should be referred to centers with high 
expertise in the diagnosis and management of this anomaly for a detailed neurosonogram, to 
confirm the diagnosis and look for associated CSN and extra CNS anomalies, which can occur in 
almost half of cases and which significantly impact the prognosis of these children (Fig. 4). Prenatal 
invasive diagnosis to rule out chromosomal anomalies should be offered to parents in view of the 
high risk of aneuploidies even in fetuses presenting with isolated ACC on the scan. CMA should be 
also performed to rule out significant CNVs which can be associated with ACC in about 6% of 
fetuses with isolated ACC and normal standard karyotype.  
NGS “panels”, exome and whole genome sequencing have an important role in this diagnostic iter.  
Serial follow up scans during pregnancy are warranted in order to look for associated anomalies 
which can become evident only later on in gestation. Fetal MRI should be performed, if not at the 
time of the diagnosis, in the third trimester of pregnancy in order to detect anomalies of the cortical 
surface which are usually not easily detected on ultrasound.  However, parents should be counselled 
that prenatal imaging is not completely able to rule out all anomalies and that a significant 
proportion of these may become evident only after birth. 
Post-natal assessment should include a MRI scan and a thorough examination by a pediatric 
dismorphologist in order to rule out genetic syndromes which are common in case of ACC. 
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Children should be undergo a strict follow-up in order to early identify neuropsychological 
disorders which can be amenable of supportive therapy. Treatment in symptomatic children include 
antiepileptic drug in those presenting epilepsy, psycho and speech therapy. 
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OTHER DEVELOPEMNTAL ANOMALIES OF THE CORPUS CALLOSUM  
 
1. Corpus callosum hypoplasia  
CC hypoplasia is defined as complete thinning of the CC with intact morpphology15,75. 
CC hypoplasia is a rare developmental disorder, which can recognize different etiologies such as 
radiations, alcohol, teratogens, infection, compression due to  intra-cranial masses, ischemia and 
metabolic disorders76. CC hypoplasia is commonly associated with other CNS and extra-CNS 
anomalies while isolated cases have been rarely reported in the published literature.   
Prenatal diagnosis of CC hypoplasia is challenging and can be suspected when the length of the CC, 
measured in the midsagittal plane of the fetal brain, is below the 10th centile for the gestational 
age45,77,78. Neurodevelopmental outcome of children presenting with CC hypoplasia is variable and 
strictly dependent upon the presence of co-existing CNS anomalies, especially microcephaly. 
Although asymptomatic cases have been sporadically reported, mental and psychomotor delay are 
common in children affected by CC hypoplasia especially when associated with other CNS 
anomalies79-80. Moreover, literature reports a straight correlation of this finding with autism. 
Casanova et al. in a series of 17 autistic adolescents report a smaller CC in autistic individuals when 
examined against controls 81. 
 
2. Corpus callosum dysgenesis and dysplasia 
CC dysgenesis and dysplasia refer to rare developmental anomalies of the CC characterized by an 
abnormal shape and structure, which can co-exist with callosal hypoplasia and other CNS and extra-
CNS anomalies. It may be due to genetic, infective, metabolic, environmental or extrinsic causes 
such lipoma, interhemispheric cyst or disorders of  neuronal migration82,83. In clinical practice, it is 
also used as a synonym of ACC either complete or partial although they represent separate entities 
with different etiology and prognosis 
CC dysplasia is a common finding in children with Piridoxine-dependent epilepsy (PDE), a rare 
autosomal recessive epileptic encephalopathy84 characterized by seizures starting in the neonatal 
period, resistant to common antiepileptic drugs and controlled by a daily administration of 
pyridoxine. 
Prenatal diagnosis of CC dysplasia and dysgenesis is not commonly reported in the published 
literature and it is commonly detected when other CNS and extra-CNS anomalies co-exist. 
Abnormal shape usually associated with hypoplasia of the CC are the most common ultrasound 
findings. 
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2. Hyperplasia of the corpus callosum (thick CC) 
Increased thickness of the CC is a rare developmental anomaly rarely reported on pediatric brain 
imaging. Although it can present as an isolated finding, it is usually part of complex developmental 
anomalies involving different organ systems and has been described in children with Cohen 
Syndrome85 in association with microcephaly and in cases affected by neurofibromatosis together 
with macrocephaly and white matter abnormalities86. 
Neurodevelopmental outcome of children with a tick CC is challenging. The anomaly has been only 
sporadically reported prenatally and the large majority of diagnosed cases presents with associated 
major CNS anomalies which significantly impact the prognosis  In a recent series of 9 cases 
presenting with tick CC on prenatal imaging, CC thickness normalized during the third trimester of 
pregnancy and neurodevelopmental outcome (available for 6 patients) was normal87. 
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Table 1. Disorders of prosencephalic development1 
 
Prosencephalic Formation Aprosencephaly 
Atelencephaly 
Prosencephalic Cleavage Holoprosencephaly 
Holotelencephaly 
Midline prosencephalic development Agenesis of corpus callosum 
Agenesis of septum pellucidum (± cerebral clefts) 
Septooptic dysplasia 
Septooptic hypothalamic dysplasia 
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Table 2. Ultrasound diagnosis of cACC in the different imaging planes  
 
 
US plane 
 
          Complete ACC 
 
Mid sagittal view 
 
 
Primary sign 
 Non-visualization of CC 
 
Secondary signs 
 Visualization on abnormal course of pericallosal artery 
 Radial disposition of the sulci on the internal aspecs of the hemisphere 
 
 
Axial view 
 
 
Primary sign 
 Non-visualization of CSP from 18 weeks of gestation 
 
Secondary signs 
 Frontal horns displaced from the midline  
 Colpocephaly 
 
Coronal view 
 
Primary sign 
 Non-visualization of CSP 
 
Secondary signs 
 Frontal horns displaced from the midline 
 
 
 
Partial ACC 
 
 
Mid sagittal view 
 
 
Primary sign 
 Partial visualization of the CC (missing splenium) 
 
Secondary signs 
 Shorten course of pericallosal artery 
 
 
Axial view 
 
 
Primary sign 
 Abnormal shape of the CSP  
 Absent CSP (not common) 
 
Coronal view 
 
Primary sign 
 Partial visualization of the CC (missing splenium) 
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Table 3. Incidence of abnormal neurodevelopmental outcome in children with isolated ACC 
(adapted from D’Antonio et al.) 
 
 
Neurodevelopmental outcome Pooled proportions (95% CI) 
Complete ACC 
Normal 76.04 (64.3-86.1) 
Borderline/Moderate 16.04 (7.6-26.8) 
Severe 8.15 (2.5-16.8) 
 
 
Gross motor 4.40 (0.6-11.3) 
Fine motor 10.98 (4.1-20.6) 
Cognitive 19.51 (10.1-31.1) 
Epilepsy 6.80 (1.7-14.9) 
Intelligence 21.30 (11.5-33.2) 
Sensory 0 (0-9.2) 
Visual 15.84 (4.3-32.9) 
Coordination 9.50 (3.2-18.7) 
Language 8.02 (2.1-17.3) 
Partial  ACC 
Normal 71.42 (53.1-86.7) 
Borderline/Moderate 14.92 (4.2-30.7) 
Severe 12.52 (2.9-27.5) 
 
Gross motor 0 (0-23.0) 
Fine motor 11.74 (0.9-32.1) 
Cognitive 17.25 (3.0-39.7) 
Epilepsy 16.11 (2.53.2) 
Intelligence 12.40 (1.1-33.1) 
Sensory 0 (0-23.0) 
Visual 0 (0-23.0) 
Coordination 11.74 (0.9-32.1) 
Language 17.25 (3.0-39.7) 
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Figure legend 
Figure 1. Normal brain anatomy in the first (a,b) and second (c,d,e) trimester of pregnancy. 
Figure 2. Sonography of a normal brain (a,b,c,d,e) and of a fetus affected by complete ACC (f,g,h,i) 
at the time of the anomaly scan (21 weeks of gestation) in axial, sagittal and coronal views. With 
complete agenesis, the anatomical complex formed by CC and CSP is completely absent, the inter-
hemispheric fissure is enlarged, and the frontal horns (FH) are more separated than normal.  
Figure 3. Sonography of a normal brain (a,b,c,d,e) and of a fetus affected by partial ACC at the 
time of the anomaly scan (21 weeks of gestation) in axial, sagittal and coronal views. In pACC, the 
findings are subtler compared to cACC, and the CC and CSP are present but shortened (3v = third 
ventricle). In sagittal view, a small portion of the CC can be identified. Please note the abnormal 
shape of the CSP with its antero-posterior and transverse diameters almost equal in size. 
Figure 4. Pre-natal management of fetuses suspected to be affected by ACC 
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Highlights 
 
- Midline anomalies are conditions caused by an abnormal process of ventral induction. 
 
- These anomalies could be diagnosed on prenatal ultrasound. 
 
- Neurodevelopmental outcome is directly related to the type and cause of anomaly. 
 
-  Neurodevelopmental outcome is related to associated anomalies. 
